Is the response to antihypertensive drugs heterogeneous? Rationale for personalized approach [0.03%]
抗高血压药物的治疗反应存在异质性吗？个性化医疗的合理性分析
Mario Muselli,Raffaella Bocale,Stefano Necozione et al.
Mario Muselli et al.
Arterial hypertension represents the most important cardiovascular risk factor with a direct responsibility for a large share of cardiovascular mortality and morbidity in the world. Despite the wide availability of antihypertensive therapie...
Ablation of the epicardial substrate in patients with long-QT syndrome at risk of sudden death [0.03%]
长QT综合征患者突发死亡的 epicardial 底物消融治疗
Carlo Pappone,Antonio Boccellino,Giuseppe Ciconte et al.
Carlo Pappone et al.
Sudden cardiac death remains a critical public health concern globally, affecting millions annually. Recent advances in cardiac arrhythmia mapping have demonstrated that the ventricular epicardial region has a critical arrhythmogenic role i...
Immediate multivessel revascularization after myocardial infarction: change of strategy? [0.03%]
急性心肌梗死后立即进行多支血管血运重建：改变策略吗？
Piera Capranzano,Luca Lombardo
Piera Capranzano
Multivessel coronary artery disease (MVD) is a frequently encountered condition in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) of the culprit vessel. Several s...
ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events [0.03%]
意大利抗凝治疗反转剂用于出血或高出血风险患者专家共识文档
Leonardo De Luca,Francesco Rocco Pugliese,Beniamino Susi et al.
Leonardo De Luca et al.
In recent decades, an incredible evolution in antithrombotic therapies used for treating patients with atherosclerosis, atrial fibrillation, and venous thromboembolism has been observed, leading to the availability of increasingly safe drug...
Irma Bisceglia,Elio Venturini,Maria Laura Canale et al.
Irma Bisceglia et al.
Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation but also a pillar of preventive cardio-oncology. Cardio-oncology rehabilitation is a comprehensive model based on a multitargeted approach and...
Italian Association of Hospital Cardiologists position paper-obesity in adults: a clinical primer [0.03%]
意大利医院心脏病学会立场文件-成人肥胖症：临床入门指南
Stefania Angela Di Fusco,Edoardo Mocini,Mauro Gori et al.
Stefania Angela Di Fusco et al.
Obesity is a chronic and relapsing disease characterized by the interaction between individual predispositions and an obesogenic environment. Recent advances in understanding the mechanisms of energetic homoeostasis paved the way to more ef...
Italian Association of Hospital Cardiologists Position Paper 'Gender discrepancy: time to implement gender-based clinical management' [0.03%]
意大利医院心脏病学家协会关于性别差异的立场文件：“是时候实施基于性别的临床管理”
Fabiana Lucà,Daniela Pavan,Michele Massimo Gulizia et al.
Fabiana Lucà et al.
It has been well assessed that women have been widely under-represented in cardiovascular clinical trials. Moreover, a significant discrepancy in pharmacological and interventional strategies has been reported. Therefore, poor outcomes and ...
Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention [0.03%]
意大利医院心脏病学家协会（ANMCO）关于二级心血管预防简化的药物治疗方案的科学声明
Leonardo De Luca,Stefania Angela Di Fusco,Gianmarco Iannopollo et al.
Leonardo De Luca et al.
The issue of suboptimal drug regimen adherence in secondary cardiovascular prevention presents a significant barrier to improving patient outcomes. To address this, the utilization of drug combinations, specifically single pill combinations...
Correction to: Screening for dilated cardiomyopathy in immediate family members: to whom, how, when (and where) [0.03%]
对扩张型心肌病患者的一线亲属筛查：筛选谁、如何、何时（以及在哪里）的更正通知
[This corrects the article DOI: 10.1093/eurheartjsupp/suae024.]. © The Author(s) 2024. Published by Oxford University Press on behalf of the European So...
Controversy in cardiology: clopidogrel or acetylsalicylic acid in the treatment of chronic coronary syndromes? [0.03%]
心血管病学争议：慢性冠脉综合征的治疗是选择氯吡格雷还是阿司匹林？
Laura Gatto,Lorenzo Scalia,Flavio Giuseppe Biccirè et al.
Laura Gatto et al.
Secondary prevention of patients with chronic coronary syndrome is based on the long-term use of a single anti-aggregating drug which is traditionally represented by acetylsalicylic acid (ASA) in light of the results of studies and meta-ana...